Network


Latest external collaboration on country level. Dive into details by clicking on the dots.

Hotspot


Dive into the research topics where Ayako Yawata is active.

Publication


Featured researches published by Ayako Yawata.


Cancer Chemotherapy and Pharmacology | 2005

Polymorphic tandem repeat sequences of the thymidylate synthase gene correlates with cellular-based sensitivity to fluoropyrimidine antitumor agents

Ayako Yawata; Su-Ryang Kim; Atsuko Miyajima; Takashi Kubo; Seiichi Ishida; Yoshiro Saito; Yukiko Nakajima; Noriko Katori; Yoshiaki Matsumoto; Masamichi Fukuoka; Yasuo Ohno; Shogo Ozawa; Jun-ichi Sawada

Purpose: Thymidylate synthase (TS) is one of the target molecules for the antitumor effects of fluoropyrimidine drugs. The cellular thymidylate synthase level is one of the determining factors for the antitumor activity of fluoropyrimidines. TYMS, which encodes TS, has been reported to possess 28-bp tandem repeat sequences in its 5′-untranslated region, the number of which varies. In addition, single nucleotide polymorphisms have also been shown in a triple repeat sequence. In this study, correlation between the polymorphic tandem repeat sequences of the TYMS gene and the antitumor activities of 5-fluorouracil (5-FU) and 5-fluoro-2′-deoxyuridine (FUdR) were investigated with 30 established human cell lines derived from solid tumors. Methods: A reporter assay system was developed in order to compare the ability of the transactivation mediated by the double (2R) and triple (c- or g-type, 3Rc or 3Rg, respectively) repeat sequences using a human colon cancer cell line, DLD-1. The 50% inhibitory concentration (IC50) of cell growth by 5-FU and FUdR was measured with 30 different established cell lines of human solid tumors. Genotypes based on the number of the 28-bp TYMS tandem repeat for the above cell lines were determined by electrophoretical analysis of PCR products containing the repeat sequences and nucleotide sequencing. Results: The reporter activity mediated by the 3Rg sequence was significantly higher than that by the 2R and 3Rc sequences. Activities mediated by the 2R and 3Rc sequences were comparable. According to the reporter assay, 2R and 3Rc were judged as low TS expression alleles and 3Rg as a high TS expression allele. On the basis of IC50 values, cells possessing the 2R/2R and 2R/3R repeat of TYMS were significantly more sensitive to FUdR than those with the 3R/3R repeat. Cells possessing 3Rg/3Rg (a high TS expression genotype) were significantly less sensitive to FUdR than cells with 2R/2R, 2R/3Rc, and 3Rc/3Rc (low TS expression genotypes). Conclusions: Our results of the reporter assays using 2R, 3Rc, and 3Rg repeat sequences prompted us to classify 3Rg as a high TS expression allele, and 2R and 3Rc as low TS expression alleles. The cells with low TS expression alleles were shown to exhibit significantly higher FUdR sensitivity than the cells with high TS expression alleles for the first time. These results were consistent with numerous previous in vitro and in vivo findings that tumors showing high TS expression were less sensitive to fluoropyrimidines. These results support the idea that genotyping the tandem repeat sequences of TYMS in the 5′-untranslated region is useful for individualized therapy involving fluoropyrimidine antitumor drugs.


European Journal of Pharmaceutical Sciences | 2009

Inhibition of nucleoside transport and synergistic potentiation of methotrexate cytotoxicity by cimicifugoside, a triterpenoid from Cimicifuga simplex.

Ayako Yawata; Yuko Matsuhashi; Hanako Kato; Keiko Uemura; Genjiro Kusano; Junko Ito; Toshiyuki Chikuma; Hiroshi Hojo

Cimicifugoside, a triterpenoid isolated from Cimicifuga simplex, which has been used as a traditional Chinese medicine due to its anti-inflammatory, analgesic or anti-pyretic action, was examined for inhibition of nucleoside transport and synergistic potentiation of methotrexate cytotoxicity. Cimicifugoside inhibited uptake of uridine, thymidine and adenosine in human leukemia U937 cells with the low nanomolar IC(50) values, but did not affect that of uracil, leucine or 2-deoxyglucose at <or=100 nM. Cimicifugoside analogs differentially inhibited uridine uptake in the order cimicifugoside>cimicifugenin (aglycon of cimicifugoside)>bugbanoside B>cimicifugenin A, O-methyl cimicifugenin and bugbanoside A. Cimicifugoside had less affinity for the binding site of nitrobenzylthioinosine (typical high-affinity inhibitor of equilibrative nucleoside transporter-1) in U937 cells, K562 cells and human erythrocyte membranes compared with the prototype nucleoside transport inhibitor dipyridamole. Cimicifugoside markedly potentiated methotrexate cytotoxicity in a culture of U937 cells and human carcinoma KB cells. Potentiation of methotrexate cytotoxicity by cimicifugoside analogs in U937 cells was in proportion to their inhibitory activity against uridine uptake. The present study demonstrates that cimicifugoside is a novel specific nucleoside transport inhibitor that displays synergistic potentiation of methotrexate cytotoxicity.


Scientific Reports | 2016

Changes in intracellular copper concentration and copper-regulating gene expression after PC12 differentiation into neurons

Yasumitsu Ogra; Aya Tejima; Naohiro Hatakeyama; Moeko Shiraiwa; Siyuan Wu; Tsutomu Ishikawa; Ayako Yawata; Yasumi Anan; Noriyuki Suzuki

It is suspected that some neurodegenerative diseases are a result of the disturbance of copper (Cu) homeostasis, although it remains unclear whether the disturbance of Cu homeostasis has aberrant effects on neurons. Herein, we investigated Cu metabolism specifically in neurons in terms of changes in the intracellular Cu concentration and the expression of Cu-regulating genes, such as Cu transporters and metallothioneins (MTs), before and after the differentiation of rat pheochromocytoma cells (PC12 cells) into neurons. After the differentiation, Cu and Zn imaging with fluorescent probes revealed an increase in intracellular Cu concentration. The concentrations of other essential metals, which were determined by an inductively coupled plasma mass spectrometer, were not altered. The mRNA expression of the Cu influx transporter, Ctr1, was decreased after the differentiation, and the differentiated cells acquired tolerance to Cu and cisplatin, another substrate of Ctr1. In addition, the expression of MT-3, a brain-specific isoform, was increased, contrary to the decreased expression of MT-1 and MT-2. Taken together, the differentiation of PC12 cells into neurons induced MT-3 expression, thereby resulting in intracellular Cu accumulation. The decrease in Ctr1 expression was assumed to be a response aimed at abolishing the physiological accumulation of Cu after the differentiation.


Toxicology Letters | 2008

Up-regulation of hepatic heme oxygenase-1 expression by locally induced interleukin-6 in rats administered carbon tetrachloride intraperitoneally

Kenzaburo Yamaji; Yosuke Ochiai; Ken-ichi Ohnishi; Ayako Yawata; Toshiyuki Chikuma; Hiroshi Hojo

We previously reported that interleukin-6 (IL-6) was locally produced in the early period after intraperitoneal (i.p.) or subcutaneous carbon tetrachloride (CCl4) administration, but not after oral (p.o.) administration. In the present study, we focused on the up-regulation of stress-inducible proteins induced by IL-6 after i.p. CCl4 administration. The expression of heme oxygenase-1 (HO-1) (EC 1.14.99.3) mRNA and protein were induced more in rats administered CCl4 via the i.p. route, compared with the p.o. route; however, expression of heat shock protein (HSP) 72 and HSP90 mRNA were increased to similar extents in both experimental groups. The induction of HO-1 mRNA and protein after i.p. CCl4 administration were significantly reduced after pretreatment with anti-rat IL-6 antibody. Activation of the signal transducer and activator of transcription factor 3 (STAT3), which promotes HO-1 expression, peaked together with plasma levels of IL-6 after i.p. CCl4 administration, suggesting that hepatic HO-1 expression was increased by IL-6 via the Janus kinase/STAT3 pathway. The present data indicate that hepatic HO-1 is up-regulated by endogenously produced IL-6, in addition to its up-regulation by heme derived from cytochrome P450 which has already been reported in rats administered i.p. CCl4. The up-regulation of hepatic HO-1 expression may reduce the tissue injury to livers caused by CCl4.


Journal of Toxicological Sciences | 2016

Metallomics approach to changes in element concentration during differentiation from fibroblasts into adipocytes by element array analysis.

Yasumitsu Ogra; Shu Nagasaki; Ayako Yawata; Yasumi Anan; Koichi Hamada; Akihiro Mizutani

We aimed to establish an element array analysis that involves the simultaneous detection of all elements in cells and the display of changes in element concentration before and after a cellular event. In this study, we demonstrated changes in element concentration during the differentiation of 3T3-L1 mouse fibroblasts into adipocytes. This metallomics approach yielded unique information of cellular response to physiological and toxicological events.


Journal of Health Science | 2010

Comparison of Selenium Metabolism in Three Brassicaceae Plants

Ayako Yawata; Yasuko Oishi; Yasumi Anan; Yasumitsu Ogra


Metallomics | 2013

Analysis of animal and plant selenometabolites in roots of a selenium accumulator, Brassica rapa var. peruviridis, by speciation.

Yasumitsu Ogra; Ayane Katayama; Yurie Ogihara; Ayako Yawata; Yasumi Anan


Metallomics | 2012

Distribution and metabolism of selenite and selenomethionine in the Japanese quail

Yasumi Anan; Ai Ohbo; Yuta Tani; Yoshiko Hatakeyama; Ayako Yawata; Yasumitsu Ogra


Bulletin of Environmental Contamination and Toxicology | 2012

Comparison in Accumulation of Lanthanide Elements Among Three Brassicaceae Plant Sprouts

Yasumi Anan; Yumi Awaya; Yurie Ogihara; Miyuki Yoshida; Ayako Yawata; Yasumitsu Ogra


日本毒性学会学術年会 The 6th International Congress of Asian Society of Toxicology | 2012

Distribution and metabolism of inorganic- and organic selenocompounds in Japanese quail

Yasumi Anan; Ai Ohbo; Yuta Tani; Yoshiko Hatakeyama; Ayako Yawata; Yasumitsu Ogra

Collaboration


Dive into the Ayako Yawata's collaboration.

Top Co-Authors

Avatar
Top Co-Authors

Avatar

Yasumi Anan

Showa Pharmaceutical University

View shared research outputs
Top Co-Authors

Avatar

Hiroshi Hojo

Showa Pharmaceutical University

View shared research outputs
Top Co-Authors

Avatar

Toshiyuki Chikuma

Showa Pharmaceutical University

View shared research outputs
Top Co-Authors

Avatar

Yurie Ogihara

Showa Pharmaceutical University

View shared research outputs
Top Co-Authors

Avatar

Ai Ohbo

Showa Pharmaceutical University

View shared research outputs
Top Co-Authors

Avatar

Ayane Katayama

Showa Pharmaceutical University

View shared research outputs
Top Co-Authors

Avatar

Yoshiko Hatakeyama

Showa Pharmaceutical University

View shared research outputs
Top Co-Authors

Avatar

Yuta Tani

Showa Pharmaceutical University

View shared research outputs
Top Co-Authors

Avatar
Researchain Logo
Decentralizing Knowledge